Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis C
AUTOR(ES)
Fábregas, Bruno, Moura, Alexandre, Ávila, Renata, Carmo, Ricardo, Teixeira, Antônio Lúcio
FONTE
Rev. Bras. Psiquiatr.
DATA DE PUBLICAÇÃO
2014-04
RESUMO
Documentos Relacionados
- Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability
- Treatment of chronic hepatitis C with recombinant interferon alfa.
- Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor
- Atomoxetine Used Adjunctively With Selective Serotonin Reuptake Inhibitors to Treat Depression
- Development of neovascular glaucoma in the course of interferon alfa therapy for hepatitis type C